National Comprehensive Cancer Network

About NCCN

NCCN News

NCCN welcomes the opportunity to work with reporters on all cancer-related topics. NCCN offers members of the media access to scientific and medical experts, news releases, background research, and much more. We can also help connect press with investigators and clinicians who can discuss research, treatment and issues related to cancer through coordination with media contacts at NCCN Member Institutions.

For news, interviews, photo requests or the most current information and resources available, please contact:

Katie Kiley Brown
Communications Manager
215.690.0238
brown@nccn.org
Request an Interview

Note: NCCN neither reviews nor approves press releases announcing the inclusion of tests, agents, and/or therapies listed within the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). For any additional commercial use of NCCN Content in promotional and educational materials, NCCN requires a license and review of content.

Newsroom

Press kits, media advisories, and information on upcoming events.

Press Releases

• NCCN Guidelines to Include Categories of Preference  (09/15/2017)
• NCCN Announces First Patient Dosed in NCCN-Peregrine Pharmaceuticals Collaborative Study of Bavituximab   (09/07/2017)
• NCCN Chemotherapy Order Templates to be Integrated into MEDITECH’s Web EHR  (09/07/2017)
• NCCN Guidelines to be Integrated into the Evinance Decision Support Platform  (08/23/2017)

View more >

Health Care Policy News

• Narrow Insurance Networks Leave Patients with Little Choice   (07/06/2017)
• What’s Next? NCCN Gathers Health Care Policy Experts to Deliberate Challenges to Patient Safety and Access to Cancer Care under the New Administration   (06/01/2017)
• NCCN Survey: AHCA Would Impede Overall Access to Cancer Treatment (The Cancer Letter)  (04/25/2017)
• NCCN Survey Reveals Oncology’s Concerns about Financial Distress, Patient Access to Care  (04/19/2017)

View more >

NCCN eBulletin Newsletter

September 18, 2017 | Volume 9 Issue 19

• NCCN Guidelines to Include Categories of Preference
• NCCN Flash Update: Systemic Light Chain Amyloidosis, Acute Lymphoblastic Leukemia, NCCN Templates^®, & NCCN Guidelines with NCCN Evidence Blocks™
• NCCN Flash Update: NCCN Templates^®
• NCCN Flash Update: Pancreatic Adenocarcinoma

September 5, 2017 | Volume 9 Issue 18

• NCCN Guidelines to be Integrated into the Evinance Decision Support Platform
• Register today! NCCN 12^th Annual Congress: Hematologic Malignancies™
• NCCN Flash Update: NCCN Guidelines^® & NCCN Compendium^® Updated
• NCCN Flash Update: NCCN Guidelines^® & NCCN Compendium^® Updated
• NCCN Flash Update: NCCN Guidelines^® & NCCN Compendium^® Updated
• NCCN Oncology Policy Report: Value Tools for Patients in Cancer Care

View more >

NCCN in the News

• Few Women with History of Breast and Ovarian Cancer Take Recommended Genetic Test (UCLA Fielding School of Public Health)  (08/18/2017)
• September is Prostate Cancer Awareness Month (WOAY-TV ABC)  (08/18/2017)
• New NCCN Patient Resources for Rectal Cancer Now Available  (08/11/2017)
• Black Men Have Lowest Survival Rates Among Patients with Anal Cancer  (08/09/2017)

View more >

NCCN Member Institutions in the News

• NCCN Announces First Patient Dosed in NCCN-Peregrine Pharmaceuticals Collaborative Study of Bavituximab   (09/07/2017)
• Link between Air Pollution and Cancer Risk (Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance)  (08/18/2017)
• GIST Tumors Linked To NF1 Mutations, Genetic Testing Needed (UC San Diego Moores Cancer Center)  (08/18/2017)
• Lab Tests Show Molecule Appears to Spur Cell Death in Tumors, Inflammation (Duke Cancer Institute)  (08/17/2017)

View more >